PACE-C

Name No. For Patients with Purpose
PACE-C CTRIAL-IE 15-46

Intermediate/high risk prostate cancer

The purpose of PACE-C is to determine whether prostate stereotactic body radiotherapy (SBRT) is non-inferior to conventional radiotherapy for freedom from biochemical/clinical failure in intermediate/high risk prostate cancer.


IRONMAN: International Registry for Men with Advanced Prostate Cancer

Name No. For Patients with Purpose
IRONMAN: International Registry for Men with Advanced Prostate Cancer CTRIAL-IE 17-30

Metastatic hormone-sensitive prostate cancer (mHSPC) or castration-resistant prostate cancer (CRPC)

The purpose of this study is to create an international, population-based,
prospective registry of minimum 5,000 men with advanced prostate cancer.


PEACE III

Name No. For Patients with Purpose
PEACE III CTRIAL-IE 16-21

asymptomatic or mildly symptomatic castration resistant prostate cancer patients metastatic to bone

The purpose of this study is to find out whether the combination of Xofigo® (radium-223) and Xtandi® (enzalutamide) shows better activity against Xtandi® alone (enzalutamide) in metastatic prostate cancer and if the combination of Xofigo® (radium-223) and Xtandi® (enzalutamide) is safe.


NRG GU005

Name No. For Patients with Purpose
NRG GU005 CTRIAL-IE 18-02

Localised intermediate risk prostate cancer

To determine if stereotactic body radiation therapy (SBRT) is superior to hypofractionated intensity modulated radiation therapy (IMRT) in the treatment of localised intermediate risk prostate cancer.


Tiger

Name No. For Patients with Purpose
Tiger 11-34

Testicular tumours that have returned.

The purpose of this trial is to compare two different doses of chemotherapy.